We are using our powerful mammalian cell-based Microcycle® discovery platform to build a pipeline of innovative cyclic peptide and small molecule drugs addressing intracellular targets, with a focus on cancer, immunology and inflammation.
Our Microcycles® are compact, rigid macrocycles that behave like small molecules, allowing the discovery of novel, and more effective drugs.
Vision
Our goal and passion is to transform the lives of patients by developing groundbreaking approaches to the treatment of challenging diseases.
Science
Our pioneering high-throughput, intracellular Microcycle platform enables the discovery of smaller and compact, peptide macrocycles by functional screening of a gene-encoded library against targets inside a living mammalian cell.
Pipeline
We are building a pipeline of innovative macrocycle-derived drugs that address high priority intracellular disease targets with a focus on cancer, immunology and inflammation. The unique properties of Microcycles unlocks targets that conventional methods have struggled to reach, as well as finding hidden binding sites and functional modulators.
Latest News
